Topics

12/17/18

Nonprescription use of Ritalin may cause irreversible structural changes in certain areas of the brain, according to researchers in the Department of Pharmacology and Toxicology and UB’s Clinical and Research Institute on Addictions (CRIA).

11/20/18

Cytocybernetics, a UB spinoff founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

2/1/18

Cytocybernetics, a UB spinoff co-founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has been awarded $1.5 million by the National Institutes of Health (NIH) to develop an enhanced version of a device it created that integrates electronics with heart muscle cells to test how new drugs affect the heart’s electrical activity.

1/16/18

University at Buffalo spinoff POP Biotechnologies Inc. (POP BIO) ended 2017 on a high note with a flurry of activity, including reaching research agreements with two international pharmaceutical companies.

6/1/16

Department of Biomedical Engineering researchers have developed a new drug-making technique that could lead to safer forms of injectable medicine.

Topics

Clear All Filters